Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Insensitive Nuclei Enhanced by Polarization Transfer (INEPT)01:15

Insensitive Nuclei Enhanced by Polarization Transfer (INEPT)

1.2K
Insensitive Nuclei Enhanced by Polarization Transfer (INEPT) is an advanced Nuclear Magnetic Resonance (NMR) technique specifically designed to detect and enhance the signals of low-abundance nuclei, such as carbon-13 and nitrogen-15, in small molecules. The fundamental principle behind INEPT is the transfer of polarization from a more abundant and highly polarizable nucleus, typically hydrogen-1, to the low-abundance nucleus of interest. This process effectively boosts the NMR signal of the...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Obstetric management for stillbirth complicated by a prior cesarean delivery: a cost-effectiveness analysis.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·2020
Same author

In Reply.

Obstetrics and gynecology·2020
Same author

The Cost of a Fall Among Older Adults Requiring Emergency Services.

Journal of the American Geriatrics Society·2020
Same author

Predicting vaginal birth after previous cesarean: Using machine-learning models and a population-based cohort in Sweden.

Acta obstetricia et gynecologica Scandinavica·2020
Same author

Extending the second stage of labor in nulliparous women with epidural analgesia: a cost-effectiveness analysis.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·2020
Same author

In Reply.

Obstetrics and gynecology·2020
Same journal

Amniotic Fluid Embolism: A Silent Threat to Maternal Life- An Up-to-Date Comprehensive Review of the Pathophysiology, Diagnosis, and Outcome.

Obstetrical & gynecological survey·2026
Same journal

A System Review of Pathophysiology, Diagnosis, and Clinical Management of Intrauterine Adhesions.

Obstetrical & gynecological survey·2026
Same journal

Atrial Fibrillation and Atrial Flutter in Pregnancy: Epidemiology, Pathophysiology, and Management.

Obstetrical & gynecological survey·2026
Same journal

Heavy Menstrual Bleeding in the Gynecology Clinic: A Call for Awareness and Standardized Screening for Underlying Bleeding Disorders.

Obstetrical & gynecological survey·2026
Same journal

Uterine Sarcomas: Clinical Management and a Review of Systemic Therapy.

Obstetrical & gynecological survey·2026
Same journal

Female Sexual Dysfunction: Current Models and Treatment Options.

Obstetrical & gynecological survey·2026
See all related articles

Related Experiment Video

Updated: Apr 26, 2026

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

2.1K

Noninvasive prenatal testing.

Jamie O Lo1, Feist Cori D2, Mary E Norton3

  • 1Maternal Fetal Medicine Fellow.

Obstetrical & Gynecological Survey
|August 13, 2014
PubMed
Summary
This summary is machine-generated.

Noninvasive prenatal testing (NIPT) analyzes fetal cell-free DNA in maternal serum for higher detection of trisomy 21. This advanced screening improves accuracy in high-risk pregnancies but has limitations like test failure and potential false results.

More Related Videos

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy
09:03

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy

Published on: August 25, 2019

8.8K
FISH for Pre-implantation Genetic Diagnosis
07:34

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

40.0K

Related Experiment Videos

Last Updated: Apr 26, 2026

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

2.1K
Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy
09:03

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy

Published on: August 25, 2019

8.8K
FISH for Pre-implantation Genetic Diagnosis
07:34

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

40.0K

Area of Science:

  • Genetics
  • Maternal-Fetal Medicine
  • Molecular Diagnostics

Background:

  • Noninvasive prenatal testing (NIPT) utilizes maternal serum analysis for fetal aneuploidy screening.
  • It detects fetal cell-free DNA (cfDNA), with 3%-15% of cfDNA being of fetal origin.
  • NIPT offers improved detection rates for trisomy 21 and other chromosomal abnormalities in high-risk pregnancies.

Purpose of the Study:

  • To provide an update on current issues and clinical applications of NIPT.
  • To review the performance and limitations of NIPT for prenatal screening.
  • To inform obstetric clinicians about the evolving role of NIPT.

Main Methods:

  • Analysis of cell-free DNA (cfDNA) in maternal serum.
  • Validation in singleton pregnancies at risk for trisomy 21, 13, or 18.
  • Review of NIPT performance, including sensitivity, specificity, and failure rates.

Main Results:

  • NIPT demonstrates higher sensitivity and specificity for trisomy 21 compared to traditional screening tests.
  • The test can be performed from 9-10 weeks' gestation.
  • Reported test failure rates range from 2.6% to 5.4%, with false-positive rates of 0.2%-1% and false-negative rates also possible.

Conclusions:

  • NIPT is a rapidly advancing screening tool for common trisomies in high-risk pregnancies.
  • Despite limitations, its utilization is increasing due to improved accuracy.
  • Further evaluation of NIPT technology is expected to expand its role in prenatal diagnostics.